Entry - #614873 - PEROXISOME BIOGENESIS DISORDER 7B; PBD7B - OMIM
# 614873

PEROXISOME BIOGENESIS DISORDER 7B; PBD7B


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
22q11.21 Peroxisome biogenesis disorder 7B 614873 AR 3 PEX26 608666
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
LABORATORY ABNORMALITIES
- Low import of catalase by peroxisomes in patient fibroblasts (import increased or restored by culturing at 30 degrees C)
- Normal but inefficient import of thiolase by peroxisomes in patient fibroblasts (numbers of thiolase-positive peroxisomes increased by culturing at 30 degrees C)
MISCELLANEOUS
- Survival to ages 4-12 years
- Based on studies of cell lines
MOLECULAR BASIS
- Caused by mutation in the peroxisome biogenesis factor 26 gene (PEX26, 608666.0001)
Peroxisome biogenesis disorder - PS214100 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Peroxisome biogenesis disorder 6B AR 3 614871 PEX10 602859
1p36.32 Peroxisome biogenesis disorder 6A (Zellweger) AR 3 614870 PEX10 602859
1p36.22 Peroxisome biogenesis disorder 13A (Zellweger) AR 3 614887 PEX14 601791
1q21.1 Peroxisome biogenesis disorder 14B AR 3 614920 PEX11B 603867
1q23.2 Peroxisome biogenesis disorder 12A (Zellweger) AR 3 614886 PEX19 600279
2p15 Peroxisome biogenesis disorder 11B AR 3 614885 PEX13 601789
2p15 Peroxisome biogenesis disorder 11A (Zellweger) AR 3 614883 PEX13 601789
6p21.1 Peroxisome biogenesis disorder 4B AD, AR 3 614863 PEX6 601498
6p21.1 Peroxisome biogenesis disorder 4A (Zellweger) AR 3 614862 PEX6 601498
6p21.1 Heimler syndrome 2 AR 3 616617 PEX6 601498
6q23.3 Rhizomelic chondrodysplasia punctata, type 1 AR 3 215100 PEX7 601757
6q23.3 Peroxisome biogenesis disorder 9B AR 3 614879 PEX7 601757
6q24.2 Peroxisome biogenesis disorder 10A (Zellweger) AR 3 614882 PEX3 603164
6q24.2 ?Peroxisome biogenesis disorder 10B AR 3 617370 PEX3 603164
7q21.2 Peroxisome biogenesis disorder 1B (NALD/IRD) AR 3 601539 PEX1 602136
7q21.2 Peroxisome biogenesis disorder 1A (Zellweger) AR 3 214100 PEX1 602136
7q21.2 Heimler syndrome 1 AR 3 234580 PEX1 602136
8q21.13 Peroxisome biogenesis disorder 5A (Zellweger) AR 3 614866 PEX2 170993
8q21.13 Peroxisome biogenesis disorder 5B AR 3 614867 PEX2 170993
11p11.2 Peroxisome biogenesis disorder 8B AR 3 614877 PEX16 603360
11p11.2 Peroxisome biogenesis disorder 8A (Zellweger) AR 3 614876 PEX16 603360
12p13.31 Peroxisome biogenesis disorder 2A (Zellweger) AR 3 214110 PEX5 600414
12p13.31 Peroxisome biogenesis disorder 2B AR 3 202370 PEX5 600414
17q12 Peroxisome biogenesis disorder 3B AR 3 266510 PEX12 601758
17q12 Peroxisome biogenesis disorder 3A (Zellweger) AR 3 614859 PEX12 601758
22q11.21 Peroxisome biogenesis disorder 7B AR 3 614873 PEX26 608666
22q11.21 Peroxisome biogenesis disorder 7A (Zellweger) AR 3 614872 PEX26 608666

TEXT

A number sign (#) is used with this entry because this form of peroxisome biogenesis disorder (PBD7B) is caused by homozygous or compound heterozygous mutation in the PEX26 gene (608666) on chromosome 22q11.21. Mutation in PEX26 also causes Zellweger syndrome (PBD7A; 614872).


Description

The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).

For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.

Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.


Molecular Genetics

Matsumoto et al. (2003) identified homozygosity for a missense mutation (608666.0001) in a patient with neonatal adrenoleukodystrophy (NALD).

Matsumoto et al. (2003) identified mutations in the PEX26 gene in patients with NALD (608666.0001) and infantile Refsum disease (IRD) (608666.0005-608666.0007).


REFERENCES

  1. Matsumoto, N., Tamura, S., Fujiki, Y. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes. Nature Cell Biol. 5: 454-460, 2003. [PubMed: 12717447, related citations] [Full Text]

  2. Matsumoto, N., Tamura, S., Furuki, S., Miyata, N., Moser, A., Shimozawa, N., Moser, H. W., Suzuki, Y., Kondo, N., Fujiki, Y. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am. J. Hum. Genet. 73: 233-246, 2003. [PubMed: 12851857, images, related citations] [Full Text]

  3. Waterham, H. R., Ebberink, M. S. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim. Biophys. Acta 1822: 1430-1441, 2012. [PubMed: 22871920, related citations] [Full Text]


Creation Date:
Anne M. Stumpf : 10/15/2012
alopez : 10/26/2012
alopez : 10/25/2012
alopez : 10/16/2012
alopez : 10/16/2012
alopez : 10/16/2012

# 614873

PEROXISOME BIOGENESIS DISORDER 7B; PBD7B


ORPHA: 44, 772, 79189;   DO: 0081436;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
22q11.21 Peroxisome biogenesis disorder 7B 614873 Autosomal recessive 3 PEX26 608666

TEXT

A number sign (#) is used with this entry because this form of peroxisome biogenesis disorder (PBD7B) is caused by homozygous or compound heterozygous mutation in the PEX26 gene (608666) on chromosome 22q11.21. Mutation in PEX26 also causes Zellweger syndrome (PBD7A; 614872).


Description

The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).

For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.

Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.


Molecular Genetics

Matsumoto et al. (2003) identified homozygosity for a missense mutation (608666.0001) in a patient with neonatal adrenoleukodystrophy (NALD).

Matsumoto et al. (2003) identified mutations in the PEX26 gene in patients with NALD (608666.0001) and infantile Refsum disease (IRD) (608666.0005-608666.0007).


REFERENCES

  1. Matsumoto, N., Tamura, S., Fujiki, Y. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes. Nature Cell Biol. 5: 454-460, 2003. [PubMed: 12717447] [Full Text: https://doi.org/10.1038/ncb982]

  2. Matsumoto, N., Tamura, S., Furuki, S., Miyata, N., Moser, A., Shimozawa, N., Moser, H. W., Suzuki, Y., Kondo, N., Fujiki, Y. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am. J. Hum. Genet. 73: 233-246, 2003. [PubMed: 12851857] [Full Text: https://doi.org/10.1086/377004]

  3. Waterham, H. R., Ebberink, M. S. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim. Biophys. Acta 1822: 1430-1441, 2012. [PubMed: 22871920] [Full Text: https://doi.org/10.1016/j.bbadis.2012.04.006]


Creation Date:
Anne M. Stumpf : 10/15/2012

Edit History:
alopez : 10/26/2012
alopez : 10/25/2012
alopez : 10/16/2012
alopez : 10/16/2012
alopez : 10/16/2012